Keyphrases
Prostate Cancer
100%
ACK1
73%
Castration-resistant Prostate Cancer
55%
Phosphorylation
54%
TNK2
53%
Androgen Receptor
52%
Clear Cell Renal Cell Carcinoma (ccRCC)
47%
Essential Pathway
47%
Transcriptomic Characterization
47%
Epigenetics
47%
Progression Markers
47%
Ultrasound-guided
47%
Endobronchial Ultrasound
47%
Tumor
44%
Tyrosine Kinase
37%
Tumor Cells
36%
Non-small Cell Lung Cancer (NSCLC)
35%
Acetylation
32%
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA)
30%
Programmed Death-ligand 1 (PD-L1)
29%
Cytomorphology
28%
Spatial Transcriptomics
28%
Immunohistochemistry
27%
Therapeutic Vulnerabilities
25%
Conflict of Interest
23%
Plasma Cell Neoplasm
23%
Cytological Samples
23%
BerEP4
23%
Androgen Production
23%
Histone H2A
23%
Potential Conflict
23%
MOC31
23%
Urinary Bladder Mass
23%
PARP Inhibitor (PARPi)
23%
Insurance Medicine
23%
Transbronchial Aspiration
23%
Advanced Prostate Cancer
23%
Clinical Proteomic Tumor Analysis Consortium
23%
National Cancer Institute
23%
Declare
23%
Competing Interests
23%
Specific Antibodies
23%
Bladder Mass
23%
Epithelial Cell Adhesion Molecule (EpCAM)
23%
Vulnerability
23%
Cdc42
23%
Follicular Dendritic Cell Sarcoma
23%
Urinary Bladder
23%
Lung Cancer
23%
HOXB13
23%
Medicine and Dentistry
Prostate Cancer
97%
Diagnosis
50%
Endobronchial Ultrasonography
47%
Neoplasm
46%
Immunohistochemistry
41%
Biopsy Technique
38%
Malignant Neoplasm
31%
Cytotechnology
31%
Fine-Needle Aspiration
31%
Biological Marker
30%
Non Small Cell Lung Cancer
28%
Transbronchial Aspiration
28%
Tumor Cell
27%
Glycan
27%
Lung Cancer
23%
Follicular Dendritic Cell Sarcoma
23%
PARP1
23%
Homologous Recombination
23%
Clear Cell Renal Cell Carcinoma
23%
Epithelial Cell Adhesion Molecule
23%
Plasmacytoma
23%
Bladder
23%
Recombination Repair
23%
Transcriptomics
23%
Antibodies
23%
Homeostasis
23%
Histone H3
23%
Androgen Receptor
23%
Molecular Marker
23%
Proteomics
23%
Mass Spectrometry Imaging
23%
Histopathology
23%
Programmed Death 1 Ligand 1
23%
Metastatic Carcinoma
23%
Effusion
17%
Carcinoma
17%
PARP Inhibitor
15%
Matrix-Assisted Laser Desorption-Ionization
15%
Adenocarcinoma
13%
Hematopoietic System Malignancy
11%
Poly ADP Ribose Polymerase
11%
Health Care Cost
11%
Lung
11%
Mediastinum Mass
11%
Analysis of Variance
11%
Cytopathology
11%
Epidermal Growth Factor Receptor
10%
Reactive Oxygen Species
10%
Anaplastic Lymphoma Kinase
10%
Programmed Death-Ligand 1
10%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
56%
Epigenetics
47%
Kinase
36%
Phosphotransferase
36%
Acetylation
32%
Polysaccharide
31%
Tyrosine Kinase
30%
Receptor Tyrosine Kinase
30%
Matrix-Assisted Laser Desorption/Ionization
27%
Cancer Cell
25%
Enhancer Region
25%
Transcriptomics
23%
ATP Synthase
23%
Histone H2A
23%
Ferroxidase
23%
Ceruloplasmin
23%
Androgen Synthesis
23%
Troponin I
23%
CDC42
23%
Alpha Chain
23%
HOXB13
23%
Immune Checkpoints
23%
C-Terminus
23%
Enzyme
23%
Histone H3
23%
Homeostasis
23%
Mass Spectrometry Imaging
23%
Artificial Intelligence
23%
Facilitated Diffusion
23%
Enzalutamide
14%
Tumor Progression
14%
Mitophagy
14%
Non-Receptor Tyrosine Kinase
14%
Tyrosine
11%
Mitochondrion
9%
Troponin
8%
Population
8%
T Cell
8%
Carcinogenesis
7%
Mesenchymal-Epithelial Transition
7%
PBRM1
7%
BAP1
7%
Tamsulosin
7%
Proteogenomics
7%
Eosin
7%
Immunocompetent Cell
7%
Clinical Trial
7%
Extracellular Matrix Proteins
7%
Scleroprotein
7%
Fucosylation
7%